NOT-DA-03-023: SYNTHESIS AND DISTRIBUTION OF DRUGS OF ABUSE AND RELATED COMPOUNDS

Department of Health
and Human Services (HHS)
NIH... Turning Discovery Into Health^®

SYNTHESIS AND DISTRIBUTION OF DRUGS OF ABUSE AND RELATED COMPOUNDS

RELEASE DATE:  November 14, 2002

NOTICE:  NOT-DA-03-023

National Institute on Drug Abuse (NIDA)
 (http://www.nida.nih.gov)

The National Institute on Drug Abuse (NIDA) is soliciting proposals 
from qualified organizations having the capability to acquire and 
synthesize labeled and unlabeled drugs of abuse and other chemical 
compounds including opioid and related neuropeptides.  Qualified 
organizations must also be able to check the stability and purity of 
the compounds, maintain and store the compound inventory under secure 
conditions, and distribute the compounds to research investigators as 
directed by the NIDA Project Officer.  Qualified organizations must 
have the proper facilities, equipment and experience to complete the 
above-described tasks.  As some of the compounds may be scheduled under 
the Controlled Substances Act, demonstration of proper DEA registration 
and adequate security is mandatory.  In order to handle substances 
under the Controlled Substances Act of 1970, it is mandatory that 
offerors possess a DEA Research Registration for Schedules II to V and 
demonstrate the capability to obtain a DEA registration for Schedule I 
controlled substances.

It is anticipated that one cost reimbursement, completion type contract 
will be awarded for a period of five years with options for additional 
quantities of work each year.  RFP No. N01DA-3-7736 will be available 
electronically on or about December 11, 2002, and may be accessed 
through the FedBizOpps (URL: http://www.fedbizopps.gov) or through the 
NIDA website at the following address: (URL: 
http://www.nida.nih.gov/RFP/RFPList.html).  Please note that the RFP 
for this acquisition will be streamlined to include only the Work 
Statement, Deliverables, Reporting Requirements, Special Requirements, 
Mandatory Qualifications, Technical Evaluation Criteria, and other 
necessary Proposal Preparation Instructions.  However, all information 
required for the submission of an offer will be contained in or 
accessible through the electronic RFP package.  Response to the RFP 
will be due on or about January 24, 2003.  This advertisement does not 
commit the Government to award a contract.  See note No. 26.

Point of Contact:

David T. Lisle, Contract Specialist
Contracts Management Branch, OPRM
National Institute on Drug Abuse, NIH, DHHS
6001 Executive Boulevard, Room 3105, MSC 9543
Bethesda, MD  20892-9543
E-mail address:  [email protected]
Phone:  (301) 443-6677
Fax:  (301) 443-7595
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices